1 / 20

Global Dermatophytic Onychomycosis Market - Size, Analysis, Share, Trends to 2021

The global dermatophytic onychomycosis therapeutics market was valued at US$ 2,870 Mn in 2014. North America was the largest market for dermatophytic onychomycosis therapeutics, accounting for over 43% revenue share of the overall market in 2014, followed by Europe with around 28% share. North America market is expected to exhibit the highest CAGR of 9.2% during the forecast period (2015–2021), followed by Europe. Factors such as increasing per capita healthcare spending, rising aging population, consumers’ disposition towards maintaining aesthetic appearing nails, and growing product innovation are expected to support the growth of the dermatophytic onychomycosis therapeutics market during the forecast period.

justinbarnes12
Download Presentation

Global Dermatophytic Onychomycosis Market - Size, Analysis, Share, Trends to 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Persistence Market Research Global Dermatophytic Onychomycosis Market expected to progress US$ 4,706.3 Mn by the end of 2021 - Persistence Market Research Persistence Market Research 1

  2. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Persistence Market Research Released New Market Report “Global Market Study on Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to Account for Maximum Market Share by 2021”. The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the forecast period. By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for about 70% share of the total global dermatophytic onychomycosis market revenue by 2021. By distribution channels, the market is segmented into hospitals, dermatology and podiatry clinics, independent pharmacies, mail order pharmacies, and drug stores. Among these, drug stores are estimated to be largest segment with 47% share of the total global market revenue by 2015 end. The drug stores segment is expected to register the fastest CAGR during the forecast period. Independent pharmacies are projected to be the second most attractive segment of the global dermatophytic onychomycosis therapeutics market by 2015 end. Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market. This report covers global and regional trends along with an analysis of the market potential. North America is expected to account for over 43% revenue share of the total dermatophytic onychomycosis therapeutics market by 2015 end i.e. holding the maximum market share. Persistence Market Research 2

  3. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Whereas Europe is projected to grow at a healthy CAGR of 7.3% due to increasing awareness about fungal nail infections. Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/5840 View TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/5840 Global dermatophytic onychomycosis therapeutics market report begins with an overview of the global market in terms of value. This section includes detailed analysis of key trends, drivers and restraints, and opportunities. All of these are factors that impact market growth. Impact analysis of key growth drivers and restraints based on the weighted average of each one of these factors in a model-based approach is included in the market report to better equip clients with crystal clear decision-making insights. For more info: http://www.persistencemarketresearch.com/contact-us.asp Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care. Persistence Market Research 3

  4. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Market History: Dermatophytic onychomycosis is a fungal infection of nail caused by dermatophytes. It makes the nails look white and opaque, thickened, and brittle. People in the age group of 60- 65 years with diabetes or disease of the small blood vessels (peripheral vascular disease) are at increased risk. Dermatophytic onychomycosis therapeutics market consists of drugs used for a treatment of the disease. The global dermatophytic onychomycosis therapeutics market was valued at US$ 2,870 Mn in 2014. North America was the largest market for dermatophytic onychomycosis therapeutics, accounting for over 43% revenue share of the overall market in 2014, followed by Europe with around 28% share. North America market is expected to exhibit the highest CAGR of 9.2% during the forecast period (2015–2021), followed by Europe. Factors such as increasing per capita healthcare spending, rising aging population, consumers’ disposition towards maintaining aesthetic appearing nails, and growing product innovation are expected to support the growth of the dermatophytic onychomycosis therapeutics market during the forecast period. The global dermatophytic onychomycosis therapeutics market is projected to be valued at US$ 3,057.8 Mn by the end of 2015 and is further expected to reach US$ 4,706.3 Mn by the end of 2021, at a CAGR of 7.5%. By product, the nail paint segment accounted for about 70% share of overall market value in 2014. By treatment, the oral segment was valued at US$ 861 Mn in 2014 and is expected to increase at a CAGR of 5.2% during the forecast period to account for US$ 1,221.9 Mn by 2021. By distribution channels, the drug store segment contributed the highest revenue of US$ 1,343.2 Mn, accounting for approximately 47% market share in 2014. Independent pharmacies were the second-largest segment by distribution channel, accounting for about 20% revenue share in 2014. Key players of the global dermatophytic onychomycosis therapeutics market include Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Johnson & Johnson Services, Inc., and Anacor Pharmaceuticals, Inc. Persistence Market Research 4

  5. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Persistence Market Research 5

  6. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Table of Content 1. Assumptions and Acronyms Used 2. Research Methodology 3. Executive Summary 4. Dermatophytic Onychomycosis Therapeutics Market Overview 4.1. Introduction 4.1.1. Dermatophytic Onychomycosis Therapeutics Market Definition 4.1.2. Dermatophytic Onychomycosis Therapeutics Market Taxonomy 4.1.3. Dermatophytic Onychomycosis Therapeutics Market Parent Overview 4.2. Dermatophytic Onychomycosis Therapeutics Market Dynamics 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunity 4.2.4. Trends 5. Global Dermatophytic Onychomycosis Therapeutics Market Analysis, By Product Type 5.1. Introduction 5.1.1. Y-o-Y Growth Comparison, By Product Type 5.1.2. Market Share & Basis Point (BPS) Analysis, By Product Type 5.2. Market Forecast, By Product Type 5.2.1. Tablet 5.2.1.1. Market Size Forecast and Y-o-Y Growth 5.2.1.2. Absolute $ Opportunity 5.2.1.3. Rx. Tablet 5.2.1.3.1. Market Size Forecast and Y-o-Y Growth 5.2.1.3.2. Absolute $ Opportunity 5.2.1.4. OTC Tablet 5.2.1.4.1. Market Size Forecast and Y-o-Y Growth 5.2.1.4.2. Absolute $ Opportunity Persistence Market Research 6

  7. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 5.2.2. Nail Paint 5.2.2.1. Market Size Forecast and Y-o-Y Growth 5.2.2.2. Absolute $ Opportunity 5.2.2.3. Rx. Nail Paint 5.2.2.3.1. Market Size Forecast and Y-o-Y Growth 5.2.2.3.2. Absolute $ Opportunity 5.2.2.4. OTC Nail Paint 5.2.2.4.1. Market Size Forecast and Y-o-Y Growth 5.2.2.4.2. Absolute $ Opportunity 5.3. Market Attractiveness Analysis, By Product Type 6. Global Market Analysis, By Treatment Type 6.1. Introduction 6.1.1. Y-o-Y Growth Comparison, By Treatment Type 6.1.2. Market Share & Basis Point (BPS) Analysis, By Treatment Type 6.2. Market Forecast, By Treatment Type 6.2.1. Oral Therapy 6.2.1.1. Market Size Forecast and Y-o-Y Growth 6.2.1.2. Absolute $ Opportunity 6.2.2. Topical Therapy 6.2.2.1. Market Size Forecast and Y-o-Y Growth 6.2.2.2. Absolute $ Opportunity 6.3. Market Attractiveness Analysis, By Treatment Type 6.4. Prominent Trends 7. Global Market Analysis, By Distribution Channels 7.1. Introduction 7.1.1. Y-o-Y Growth Comparison, By Distribution Channels 7.1.2. Market Share & Basis Point (BPS) Analysis, By Distribution Channels 7.2. Market Forecast, By Distribution Channels 7.2.1. Hospital 7.2.1.1. Market Size Forecast and Y-o-Y Growth 7.2.1.2. Absolute $ Opportunity 7.2.2. Clinics 7.2.2.1. Market Size Forecast and Y-o-Y Growth Persistence Market Research 7

  8. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 7.2.2.2. Absolute $ Opportunity 7.2.3. Independent Pharmacy 7.2.3.1. Market Size Forecast and Y-o-Y Growth 7.2.3.2. Absolute $ Opportunity 7.2.4. Mail Order Pharmacies 7.2.4.1. Market Size Forecast and Y-o-Y Growth 7.2.4.2. Absolute $ Opportunity 7.2.5. Drug Stores 7.2.5.1. Market Size Forecast and Y-o-Y Growth 7.2.5.2. Absolute $ Opportunity 7.3. Market Attractiveness Analysis, By Distribution Channels 8. Global Dermatophytic Onychomycosis Therapeutics Market Analysis, By Region 8.1. Introduction 8.1.1. Y-o-Y Growth Projections, By Region 8.1.2. Market Share & Basis Point (BPS) Analysis, By Region 8.2. Market Forecast, By Region 8.2.1. North America Market Forecast 8.2.2. Europe Market Forecast 8.2.3. APAC Market Forecast 8.2.4. Latin America Market Forecast 8.2.5. MEA Market Forecast 8.3. Regional Attractiveness Analysis, By Region 9. North America Market Value Forecast 9.1. Key Trends 9.2. Market Value Forecast, By Country 9.2.1. US Absolute $ Opportunity 9.2.2. Canada Absolute $ Opportunity 9.3. Market Value Forecast, By Product Type 9.3.1. Tablet 9.3.1.1. Rx. Tablet 9.3.1.2. OTC Tablet 9.3.2. Nail Paint 9.3.2.1. Rx. Nail Paint Persistence Market Research 8

  9. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 9.3.2.2. OTC Nail Paint 9.4. Market Value Forecast, By Treatment Type 9.4.1. Oral Therapy 9.4.2. Topical Therapy 9.5. Market Value Forecast, By Distribution Channels 9.5.1. Hospital 9.5.2. Clinics 9.5.3. Independent Pharmacy 9.5.4. Mail Order Pharmacies 9.5.5. Drug Stores 9.6. Drivers & Restraints: Impact Analysis 10. Europe Market Value Forecast 10.1. Key Trends 10.2. Market Value Forecast, By Country 10.2.1. Germany Absolute $ Opportunity 10.2.2. Italy Absolute $ Opportunity 10.2.3. France Absolute $ Opportunity 10.2.4. The United Kingdom Absolute $ Opportunity 10.2.5. Spain Absolute $ Opportunity 10.2.6. Russia Absolute $ Opportunity 10.2.7. Rest of Europe Absolute $ Opportunity 10.3. Market Value Forecast, By Product Type 10.3.1. Tablet 10.3.1.1. Rx. Tablet 10.3.1.2. OTC Tablet 10.3.2. Nail Paint 10.3.2.1. Rx. Nail Paint 10.3.2.2. OTC Nail Paint 10.4. Market Value Forecast, By Treatment Type 10.4.1. Oral Therapy 10.4.2. Topical Therapy 10.5. Market Value Forecast, By Distribution Channels 10.5.1. Hospital 10.5.2. Clinics Persistence Market Research 9

  10. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 10.5.3. Independent Pharmacy 10.5.4. Mail Order Pharmacies 10.5.5. Drug Stores 10.6. Drivers & Restraints: Impact Analysis 11. APAC Market Value Forecast 11.1. Key Trends 11.2. Market Value Forecast, By Country 11.2.1. Greater China Absolute $ Opportunity 11.2.2. Japan Absolute $ Opportunity 11.2.3. India Absolute $ Opportunity 11.2.4. Rest of APEJ Absolute $ Opportunity 11.3. Market Value Forecast, By Product Type 11.3.1. Tablet 11.3.1.1. Rx. Tablet 11.3.1.2. OTC Tablet 11.3.2. Nail Paint 11.3.2.1. Rx. Nail Paint 11.3.2.2. OTC Nail Paint 11.4. Market Value Forecast, By Treatment Type 11.4.1. Oral Therapy 11.4.2. Topical Therapy 11.5. Market Value Forecast, By Distribution Channels 11.5.1. Hospital 11.5.2. Clinics 11.5.3. Independent Pharmacy 11.5.4. Mail Order Pharmacies 11.5.5. Drug Stores 11.6. Drivers & Restraints: Impact Analysis 12. Latin America Market Value Forecast 12.1. Key Trends 12.2. Market Value Forecast, By Country 12.2.1. Argentina Absolute $ Opportunity 12.2.2. Brazil Absolute $ Opportunity Persistence Market Research 10

  11. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 12.2.3. Mexico Absolute $ Opportunity 12.2.4. Rest of Latin America Absolute $ Opportunity 12.3. Market Value Forecast, By Product Type 12.3.1. Tablet 12.3.1.1. Rx. Tablet 12.3.1.2. OTC Tablet 12.3.2. Nail Paint 12.3.2.1. Rx. Nail Paint 12.3.2.2. OTC Nail Paint 12.4. Market Value Forecast, By Treatment Type 12.4.1. Oral Therapy 12.4.2. Topical Therapy 12.5. Market Value Forecast, By Distribution Channels 12.5.1. Hospital 12.5.2. Clinics 12.5.3. Independent Pharmacy 12.5.4. Mail Order Pharmacies 12.5.5. Drug Stores 12.6. Drivers & Restraints: Impact Analysis 13. MEA Market Value Forecast 13.1. Key Trends 13.2. Market Value Forecast, By Country 13.2.1. GCC Absolute $ Opportunity 13.2.2. South Africa Absolute $ Opportunity 13.2.3. Rest of MEA Absolute $ Opportunity 13.3. Market Value Forecast, By Product Type 13.3.1. Tablet 13.3.1.1. Rx. Tablet 13.3.1.2. OTC Tablet 13.3.2. Nail Paint 13.3.2.1. Rx. Nail Paint 13.3.2.2. OTC Nail Paint 13.4. Market Value Forecast, By Treatment Type 13.4.1. Oral Therapy Persistence Market Research 11

  12. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 13.4.2. Topical Therapy 13.5. Market Value Forecast, By Distribution Channels 13.5.1. Hospital 13.5.2. Clinics 13.5.3. Independent Pharmacy 13.5.4. Mail Order Pharmacies 13.5.5. Drug Stores 13.6. Drivers & Restraints: Impact Analysis 14. Competition Landscape 14.1. Brand Share Analysis 14.2. Company Profiles 14.2.1. Revenue 14.2.2. Product Types/Brand Offerings 14.2.3. Key developments 14.2.4. SWOT Analysis 14.3. Company Highlights 14.3.1. Valeant Pharmaceuticals International Inc. 14.3.2. Galderma S.A. 14.3.3. Novartis AG 14.3.4. Pfizer Inc. 14.3.5. Moberg Pharma AB 14.3.6. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.) 14.3.7. Anacor Pharmaceuticals, Inc. List of Tables Table 01: Global Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Region, 2014–2021 (US$ Mn) Table 02: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014–2021 (US$ Mn) Table 03: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014–2021 (US$ Mn) Table 04: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014–2021 (US$ Mn) Persistence Market Research 12

  13. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Table 05: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014–2021 (US$ Mn) Table 06: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014–2021 (US$ Mn) Table 07: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014–2021 (US$ Mn) Table 08: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014–2021 (US$ Mn) Table 09: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014–2021 (US$ Mn) Table 10: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014–2021 (US$ Mn) Table 11: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014–2021 (US$ Mn) Table 12: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014–2021 (US$ Mn) Table 13: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014–2021 (US$ Mn) Table 14: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Product Type, 2014–2021 (US$ Mn) Table 15: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Treatment Type, 2014–2021 (US$ Mn) Table 16: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value Forecast By Distribution Channels, 2014–2021 (US$ Mn) List of Figures Figure 01: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%), 2014–2021 Figure 02: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity, 2014–2021 Figure 03: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014–2021 Figure 04: Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Product Type, 2014 & 2021 Persistence Market Research 13

  14. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Figure 05: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Tablet Segment, 2014–2021 Figure 06: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Tablet Segment, 2014–2021 Figure 07: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Rx. Tablet Sub-segment, 2014–2021 Figure 08: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Rx. Tablet Sub-segment, 2014–2021 Figure 09: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for OTC Tablet Sub-segment, 2014–2021 Figure 10: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for OTC Tablet Sub-segment, 2014–2021 Figure 11: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Nail Paint Segment, 2014–2021 Figure 12: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Nail Paint Segment, 2014–2021 Figure 13: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Rx. Nail Paint Sub-segment, 2014–2021 Figure 14: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Rx. Nail Paint Sub-segment, 2014–2021 Figure 15: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for OTC Nail Paint Sub-segment, 2014–2021 Figure 16: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for OTC Nail Paint Sub-segment, 2014–2021 Figure 17: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015–2021 Figure 18: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Treatment Type, 2015–2021 Figure 19: Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Treatment Type, 2014 & 2021 Figure 20: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Oral Segment, 2014–2021 Figure 21: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Oral Segment, 2014–2021 Persistence Market Research 14

  15. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Figure 22: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Topical Segment, 2014–2021 Figure 23: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Topical Segment, 2014–2021 Figure 24: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2015–2021 Figure 25: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Distribution Channels, 2015–2021 Figure 26: Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Distribution Channels, 2014 & 2021 Figure 27: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Hospitals, 2014–2021 Figure 28: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Hospitals, 2014–2021 Figure 29: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Clinics, 2014–2021 Figure 30: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Clinics, 2014–2021 Figure 31: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Independent Pharmacies, 2014–2021 Figure 32: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Independent Pharmacies, 2014–2021 Figure 33: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Mail Order Pharmacies, 2014–2021 Figure 34: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Mail Order Pharmacies, 2014–2021 Figure 35: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) for Drug Stores, 2014–2021 Figure 36: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity for Drug Stores, 2014–2021 Figure 37: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channels, 2015–2021 Figure 38: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Region, 2015–2021 Persistence Market Research 15

  16. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Figure 39: Global Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Region, 2014 & 2021 Figure 40: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by North America, 2014–2021 Figure 41: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by North America, 2014–2021 Figure 42: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Europe, 2014–2021 Figure 43: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Europe, 2014–2021 Figure 44: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Asia Pacific, 2014–2021 Figure 45: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Asia Pacific, 2014–2021 Figure 46: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Latin America, 2014–2021 Figure 47: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Latin America, 2014–2021 Figure 48: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Middle East and Africa, 2014–2021 Figure 49: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Middle East and Africa, 2014–2021 Figure 50: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Region, 2015–2021 Figure 51: North America Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014–2021 Figure 52: North America Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Product Type, 2014 & 2021 Figure 53: North America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by U.S., 2014–2021 Figure 54: North America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by U.S., 2014–2021 Figure 55: North America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Canada, 2014–2021 Persistence Market Research 16

  17. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Figure 56: North America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Canada, 2014–2021 Figure 57: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015–2021 Figure 58: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2015–2021 Figure 59: Europe Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014–2021 Figure 60: Europe Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Product Type, 2014 & 2021 Figure 61: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Germany, 2014–2021 Figure 62: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Germany, 2014–2021 Figure 63: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by France, 2014–2021 Figure 64: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by France, 2014–2021 Figure 65: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by U.K., 2014–2021 Figure 66: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by U.K., 2014–2021 Figure 67: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Italy, 2014–2021 Figure 68: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Italy, 2014–2021 Figure 69: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Spain, 2014–2021 Figure 70: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Spain, 2014–2021 Figure 71: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Rest of Europe, 2014–2021 Figure 72: Europe Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Rest of Europe, 2014–2021 Persistence Market Research 17

  18. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Figure 73: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015–2021 Figure 74: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channels, 2015–2021 Figure 75: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014–2021 Figure 76: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Product Type, 2014 & 2021 Figure 77: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Japan, 2014–2021 Figure 78: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Japan, 2014–2021 Figure 79: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by China, 2014–2021 Figure 80: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by China, 2014–2021 Figure 81: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by India, 2014–2021 Figure 82: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by India, 2014–2021 Figure 83: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Australia & New Zealand, 2014–2021 Figure 84: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Australia & New Zealand, 2014–2021 Figure 85: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Rest of Asia Pacific, 2014–2021 Figure 86: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Rest of Asia Pacific, 2014–2021 Figure 87: APAC Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015–2021 Figure 88: APAC Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2015–2021 Figure 89: Latin America Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014–2021 Persistence Market Research 18

  19. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Figure 90: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Product Type, 2014 & 2021 Figure 91: Latin America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Brazil, 2014–2021 Figure 92: Latin America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Brazil, 2014–2021 Figure 93: Latin America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Mexico, 2014–2021 Figure 94: Latin America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Mexico, 2014–2021 Figure 95: Latin America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Argentina, 2014–2021 Figure 96: Latin America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Argentina, 2014–2021 Figure 97: Latin America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Rest of Latin America, 2014–2021 Figure 98: Latin America Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Rest of Latin America, 2014–2021 Figure 99: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015–2021 Figure 100: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2015–2021 Figure 101: MEA Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By Product Type, 2014–2021 Figure 102: Middle East Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis By Product Type, 2014 & 2021 Figure 103: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by GCC, 2014–2021 Figure 104: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by GCC, 2014–2021 Figure 105: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by South Africa, 2014–2021 Figure 106: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by South Africa, 2014–2021 Persistence Market Research 19

  20. Global Dermatophytic Onychomycosis Market - Asia Pacific is projected to expand at the highest CAGR by 2015 - 2021 Figure 107: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by Rest of MEA, 2014–2021 Figure 108: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by Rest of MEA, 2014–2021 Figure 109: MEA Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2015–2021 Figure 110: MEA Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channels, 2015–2021 About Us: Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs. PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values. Contact Us: Persistence Market Research 305 Broadway 7th Floor, New York City, NY 10007, United States, USA - Canada Toll Free: +1 800-961-0353 Email: sales@persistencemarketresearch.com Web: http://www.persistencemarketresearch.com Persistence Market Research 20

More Related